Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease : Does aspirin make a difference?

Aspirin (ASA) often is used to prevent thrombosis in infants with congenital heart disease after placement of a systemic-to-pulmonary artery shunt, but its effect on outcomes is unknown. The present multicenter study prospectively collected data on 1-year postoperative rates of death, shunt thrombos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2007-07, Vol.116 (3), p.293-297
Hauptverfasser: LI, Jennifer S, YOW, Eric, BONNET, Damien, MICHEL-BEHNKE, Ina, GRAHAM, Thomas P, TAKAHASHI, Masato, JAGGERS, James, CALIFF, Robert M, RAKHIT, Amit, FONTECAVE, Sylvie, SANDERS, Stephen P, BEREZNY, Katherine Y, RHODES, John F, BOKESCH, Paula M, CHARPIE, John R, FORBUS, Geoffrey A, MAHONY, Lynn, BOSHKOV, Lynn, LAMBERT, Virginie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aspirin (ASA) often is used to prevent thrombosis in infants with congenital heart disease after placement of a systemic-to-pulmonary artery shunt, but its effect on outcomes is unknown. The present multicenter study prospectively collected data on 1-year postoperative rates of death, shunt thrombosis, or hospitalization age
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.106.652172